APA (7th ed.) Citation

T, W., N, Y., N, I., S, H., K, M., S, K., . . . D, T. (2026). Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer. Targeted oncology, 21(2), 269. https://doi.org/10.1007/s11523-026-01204-5

Chicago Style (17th ed.) Citation

T, Wakatsuki, et al. "Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer." Targeted Oncology 21, no. 2 (2026): 269. https://doi.org/10.1007/s11523-026-01204-5.

MLA (9th ed.) Citation

T, Wakatsuki, et al. "Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer." Targeted Oncology, vol. 21, no. 2, 2026, p. 269, https://doi.org/10.1007/s11523-026-01204-5.